In their study, Otsuki et al. [58] assessed the levels of REST mRNA and its known and putative target genes using quantitative real-time PCR in the peripheral blood cells of patients with major depressive (MDD) and bipolar disorders (BD), both in acute depressive episode and in remission. This evidence concerns the gene REST and Behcet disease.